About Our Work For the past 30 years Morningside Pharmaceuticals Ltd has been manufacturing and supplying quality generic and branded medicines to the UK and internationally. Our mission: "Making quality healthcare an affordable and accessible reality throughout the world." Our Markets In the United Kingdom, our licensed pharmaceutical products are distributed twice daily to NHS hospitals and pharmacies. Globally, we are one of the leading medical suppliers to aid agencies, charities and NGOs – including UNICEF, the Red Cross, the World Health Organisation (WHO) and Medicines San Frontier (MSF), which is also known as Doctors Without Borders. We also work with competent national authorities, internationally, to register our UK licensed Morningside products, as well as importers, distributors and wholesalers to bring them to market. Our export success has been recognised by many awards including the UK’s most prestigious accolade – the Queen’s Award for Enterprise: International Trade. Innovation Our innovative approach embraces challenges with heavy investment, including Research & Development and launching new niche generic molecules. For both pharmacists and their patients the end result is greater choice. Examples of new niche generic products launched, include: First to launch the generic version of the contraceptive pill (Levest) in the UK, in 2010, with further first generic launches, including Glycopyrronium Bromide tablets, Nitrofurantoin Capsules and Diclofenac mouthwash. Modified ‘slow release’ or ‘prolonged release’ tablets and capsules. New ways for patients to take their medicine, such as dissolve in the mouth buccal and sublingual tablets, which are designed to help patients who have difficulty swallowed. Our unique strategy is to manage the entire end-to-end process from research & development, to registration, to sales, marketing and export within the Morningside companies. This pioneering product development approach was recognised by winning the Pharmacy Business Award for Innovation in Generics in 2017. Key Therapeutic Areas: Therapeutic areas our products cover: Cardiology Endocrinology Gastroenterology Gynaecology Immunology Neurology Oncology Rheumatology HIV & Tuberculosis United Kingdom Market MORE INFO International Market MORE INFO "Morningside launches new niche products, some of which include novel technology towards slow release formulations, bringing innovation and choice to both pharmacists and patients". Pharmacy Business Awards 2017 About this site © 2021 Morningside Pharmaceuticals Ltd. All rights reserved Registered in England No: 2672877 Postal address: 5 Pavilion Way, Castle Business Park, Loughborough, Leicestershire, LE11 5GW United Kingdom Quicklinks About Products Community News & Blog Careers Contact Us Social Media Home Privacy Policy Modern Slavery Statement Competition Law Compliance Terms & Conditions Sitemap Contact Us Website by Seed This website uses cookies to help deliver and improve our services and provide you with a much richer experience during your visit. Accept Read More